{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal HB-adMSCs",
            "NStudiesAvail": 430108,
            "NStudiesFound": 25,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 25,
            "FieldList": [
                  "OverallOfficialName",
                  "OverallOfficialRole",
                  "OverallStatus",
                  "OversightHasDMC",
                  "PatientRegistry",
                  "Phase",
                  "PointOfContactEMail",
                  "PointOfContactOrganization",
                  "PointOfContactPhone",
                  "PointOfContactPhoneExt",
                  "PointOfContactTitle",
                  "PrimaryCompletionDate",
                  "PrimaryCompletionDateType",
                  "PrimaryOutcomeDescription",
                  "PrimaryOutcomeMeasure",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "OverallOfficialName": [
                              "Djamchid Lotfi, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Withdrawn"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1",
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "February 1, 2022"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "clinical lab evaluation of level of glucose in the blood (mg/dL)",
                              "clinical lab evaluation of level of calcium in the blood (mg/dL)",
                              "clinical lab evaluation of level of albumin in the blood (g/dL)",
                              "clinical lab evaluation of level of protein in the blood (g/dL)",
                              "clinical lab evaluation of level of sodium in the blood (mol/L)",
                              "clinical lab evaluation of level of carbon dioxide in the blood (mmol/L)",
                              "clinical lab evaluation of level of potassium in the blood (mmol/L)",
                              "clinical lab evaluation of level of chloride in the blood (mmol/L)",
                              "clinical lab evaluation of level of BUN in the blood (mg/dL)",
                              "clinical lab evaluation of level of creatinine in the blood (mg/dL)",
                              "clinical lab evaluation of level of alkaline phosphatase in the blood (IU/L)",
                              "clinical lab evaluation of level of alanine aminotransferase in the blood (IU/L)",
                              "clinical lab evaluation of level of aspartate aminotransferase in the blood (IU/L)",
                              "clinical lab evaluation of level of bilirubin in the blood (mg/dL)",
                              "clinical lab evaluation of level of white blood cells in the blood (x 10^3/uL)",
                              "clinical lab evaluation of level of red blood cells in the blood (x 10^6/uL)",
                              "clinical lab evaluation of level of hemoglobin in the blood (g/dL)",
                              "clinical lab evaluation of level of hematocrit in the blood (%)",
                              "clinical lab evaluation of mean corpuscular volume in the blood (fL)",
                              "clinical lab evaluation of mean corpuscular hemoglobin in the blood (pg)",
                              "clinical lab evaluation of level of hemoglobin concentration in the blood (g/dL)",
                              "clinical lab evaluation of distribution width in the blood (%)",
                              "clinical lab evaluation of neutrophils in the blood (%)",
                              "clinical lab evaluation of lymphocytes in the blood (%)",
                              "clinical lab evaluation of monocytes in the blood (%)",
                              "clinical lab evaluation of eosinophils in the blood (%)",
                              "clinical lab evaluation of basophils in the blood (%)",
                              "clinical lab evaluation of absolute neutrophils in the blood (x 10^3/uL)",
                              "clinical lab evaluation of absolute lymphocytes in the blood (x 10^3/uL)",
                              "clinical lab evaluation of absolute monocytes in the blood (x 10^3/uL)",
                              "clinical lab evaluation of absolute eosinophils in the blood (x 10^3/uL)",
                              "clinical lab evaluation of absolute basophils in the blood (x 10^3/uL)",
                              "clinical lab evaluation of granulocytes in the blood (%)",
                              "clinical lab evaluation of absolute immature granulocytes in the blood (x 10^3/uL)",
                              "clinical lab evaluation of platelets in the blood (x 10^3/uL)",
                              "clinical lab evaluation of time for blood to coagulate (seconds)",
                              "clinical lab evaluation of international normalized ratio of blood coagulation (no unit)"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Glucose",
                              "Calcium",
                              "Albumin",
                              "Total Protein",
                              "Sodium",
                              "Total carbon dioxide",
                              "Potassium",
                              "Chloride",
                              "BUN",
                              "Creatinine",
                              "Alkaline phosphatase",
                              "Alanine aminotransferase",
                              "Aspartate aminotransferase",
                              "Total Bilirubin",
                              "White blood cell",
                              "Red blood cell",
                              "Hemoglobin",
                              "Hematocrit",
                              "Mean corpuscular volume",
                              "Mean corpuscular hemoglobin",
                              "Mean corpuscular hemoglobin concentration",
                              "Red cell distribution width",
                              "Neutrophils",
                              "Lymphs",
                              "Monocytes",
                              "Eos",
                              "Basophils",
                              "Absolute neutrophils",
                              "Absolute lymphs",
                              "Absolute monocytes",
                              "Absolute Eos",
                              "Absolute Basos",
                              "Immature granulocytes",
                              "Absolute Immature granulocytes",
                              "Platelets",
                              "Prothrombin time",
                              "INR"
                        ],
                        "NCTId": [
                              "NCT04228666"
                        ]
                  },
                  {
                        "Rank": 2,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04087889"
                        ]
                  },
                  {
                        "Rank": 3,
                        "OverallOfficialName": [
                              "Thanh Cheng, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Completed"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "November 24, 2020"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Number of subjects that require hospitalization for COVID-19",
                              "Number of subjects that develop symptoms associated with COVID-19, such as fever, shortness of breath/difficulty breathing, cough"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Incidence of hospitalization for COVID-19",
                              "Incidence of symptoms for COVID-19"
                        ],
                        "NCTId": [
                              "NCT04349631"
                        ]
                  },
                  {
                        "Rank": 4,
                        "OverallOfficialName": [
                              "Philip Waller, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Completed"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1",
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [
                              "linette@hopebio.org"
                        ],
                        "PointOfContactOrganization": [
                              "Hope Biosciences Stem Cell Research Foundation"
                        ],
                        "PointOfContactPhone": [
                              "346-900-0340"
                        ],
                        "PointOfContactPhoneExt": [
                              "102"
                        ],
                        "PointOfContactTitle": [
                              "Linette Rehkopf RPh"
                        ],
                        "PrimaryCompletionDate": [
                              "August 17, 2020"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Total number of Adverse Events and Serious Adverse Events across all subjects over 12 months."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Total Number of Adverse Events and Serious Adverse Events"
                        ],
                        "NCTId": [
                              "NCT03691909"
                        ]
                  },
                  {
                        "Rank": 5,
                        "OverallOfficialName": [
                              "Thanh Cheng, MD",
                              "Joseph Varon, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator",
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Completed"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "July 9, 2021"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Number of subjects that must be hospitalized for COVID-19 during the conduct of this study",
                              "Number of subjects who experience symptoms defined to be associated with COVID-19, such as fever, shortness of breath/difficulty breathing, cough."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Incidence of hospitalization for COVID-19",
                              "Incidence of symptoms associated with COVID-19"
                        ],
                        "NCTId": [
                              "NCT04348435"
                        ]
                  },
                  {
                        "Rank": 6,
                        "OverallOfficialName": [
                              "Fermin Labayen Beraza, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Recruiting"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1",
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "August 15, 2021"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [
                              "Number of adverse events as a measure of safety and tolerability of a single dose of HCR040 when administered by intravenous injection"
                        ],
                        "NCTId": [
                              "NCT04289194"
                        ]
                  },
                  {
                        "Rank": 7,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "Not yet recruiting"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1",
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "November 1, 2023"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Number of subjects with treatment related adverse events as assessed by analysis of adverse events including symptoms.",
                              "Number of subjects with treatment related adverse events as assessed by analysis of adverse events including abnormal findings on physical examination, vital signs, ECG, and standard laboratory examination."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Incidence of adverse events",
                              "Abnormalities of physical examination, vital signs, and laboratory test"
                        ],
                        "NCTId": [
                              "NCT04527224"
                        ]
                  },
                  {
                        "Rank": 8,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04029896"
                        ]
                  },
                  {
                        "Rank": 9,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04064957"
                        ]
                  },
                  {
                        "Rank": 10,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT03925649"
                        ]
                  },
                  {
                        "Rank": 11,
                        "OverallOfficialName": [
                              "Charles S Cox, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Active, not recruiting"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 1",
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "May 27, 2022"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "clinical lab evaluation of level of glucose in the blood (mg/dL)",
                              "clinical lab evaluation of level of calcium in the blood (mg/dL)",
                              "clinical lab evaluation of level of albumin in the blood (g/dL)",
                              "clinical lab evaluation of total protein in the blood (g/dL)",
                              "clinical lab evaluation of total sodium in the blood (mmol/L)",
                              "clinical lab evaluation of total carbon dioxide in the blood (mmol/L)",
                              "clinical lab evaluation of potassium in the blood (mmol/L)",
                              "clinical lab evaluation of chloride in the blood (mmol/L)",
                              "clinical evaluation of blood urea nitrogen (BUN) (mg/dL)",
                              "clinical evaluation of creatinine in blood (mg/dL)",
                              "clinical evaluation of alkaline phosphatase (ALP) in blood (IU/L)",
                              "clinical evaluation of alanine aminotransferase (ALT) in blood (IU/L)",
                              "clinical evaluation of aspartate aminotransferase (AST) in blood (IU/L)",
                              "clinical evaluation of total bilirubin in blood (mg/dL)",
                              "clinical evaluation of white blood cells (WBC) in blood (x 10^3/uL)",
                              "clinical evaluation of red blood cells (RBC) in blood (x 10^6/uL)",
                              "clinical evaluation of hemoglobin in blood (g/dL)",
                              "clinical evaluation of hematocrit in blood (%)",
                              "clinical evaluation of mean corpuscular volume (MCV) in blood (fL)",
                              "clinical evaluation of mean corpuscular hemoglobin (MCH) in blood (pg)",
                              "clinical evaluation of mean corpuscular hemoglobin concentration (MCHC) in blood (g/dL)",
                              "clinical evaluation of red cell distribution width (RDW) in blood (%)",
                              "clinical evaluation of neutrophils in blood (%)",
                              "clinical evaluation of lymphocytes in blood (%)",
                              "clinical evaluation of monocytes in blood (%)",
                              "clinical evaluation of eosinophils in blood (%)",
                              "clinical evaluation of basophils in blood (%)",
                              "clinical evaluation of absolute neutrophils in blood (x 10^3/uL)",
                              "clinical evaluation of absolute lymphocytes in blood (x 10^3/uL)",
                              "clinical evaluation of absolute monocytes in blood (x 10^3/uL)",
                              "clinical evaluation of absolute eosinophils in blood (x 10^3/uL)",
                              "clinical evaluation of absolute basophils in blood (x 10^3/uL)",
                              "clinical evaluation of immature granulocytes in blood (%)",
                              "clinical evaluation of absolute immature granulocytes in blood (x 10^3/uL)",
                              "clinical evaluation of platelets in blood (x 10^3/uL)",
                              "clinical evaluation of time for blood to coagulate (seconds)",
                              "clinical evaluation of international normalized ratio of blood coagulation (no unit)",
                              "clinical evaluation of human chorionic gonadotropin (hCG) in urine (positive/negative)"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Glucose",
                              "Calcium",
                              "Albumin",
                              "Total Protein",
                              "Sodium",
                              "Total carbon dioxide",
                              "Potassium",
                              "Chloride",
                              "BUN",
                              "Creatinine",
                              "Alkaline phosphatase",
                              "Alanine aminotransferase",
                              "Aspartate aminotransferase",
                              "Total Bilirubin",
                              "White blood cell",
                              "Red blood cell",
                              "Hemoglobin",
                              "Hematocrit",
                              "Mean corpuscular volume",
                              "Mean corpuscular hemoglobin",
                              "Mean corpuscular hemoglobin concentration",
                              "Red cell distribution width",
                              "Neutrophils",
                              "Lymphs",
                              "Monocytes",
                              "Eos",
                              "Basos",
                              "Absolute Neutrophils",
                              "Absolute Lymphs",
                              "Absolute monocytes",
                              "Absolute Eos",
                              "Absolute Basos",
                              "Immature Granulocytes",
                              "Absolute Immature Granulocytes",
                              "Platelets",
                              "Prothrombin Time",
                              "INR",
                              "Urine Pregnancy"
                        ],
                        "NCTId": [
                              "NCT04063215"
                        ]
                  },
                  {
                        "Rank": 12,
                        "OverallOfficialName": [
                              "Rajiv Thakur, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Terminated"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "September 30, 2021"
                        ],
                        "PrimaryCompletionDateType": [
                              "Actual"
                        ],
                        "PrimaryOutcomeDescription": [
                              "change from baseline in interleukin-6",
                              "Change from baseline in C Reactive protein",
                              "change from baseline oxygenation (%)",
                              "change from baseline in TNF alpha",
                              "change from baseline level of IL-10 in the blood (pg/mL)",
                              "Time to return to room air"
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Interleukin-6",
                              "C Reactive protein",
                              "Oxygenation",
                              "TNF alpha",
                              "IL-10",
                              "Return to room air (RTRA)"
                        ],
                        "NCTId": [
                              "NCT04362189"
                        ]
                  },
                  {
                        "Rank": 13,
                        "OverallOfficialName": [
                              "Djamchid Lotfi, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Recruiting"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "November 22, 2023"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "The MSQOL-54 is a comprehensive health-related quality of life measure incorporating general and MS-specific questions into a single instrument.\n\nThe developers used the SF-36 as a base and added 18 questions to address MS-specific problems, including fatigue and cognitive function.\n\nThis 54-item questionnaire provides 12 sub-scales, two summary scores, and two extra single-item measures. The sub-scales are physical function, role limits-physical, emotional role restrictions, pain, emotional well-being, energy, health perceptions, social position, cognitive function, health distress, overall quality of life, and sexual function. There is no single overall score for MSQOL-54. Two summary scores - physical health and mental health - can be derived from a weighted combination of scale scores (scale scores range from 0 to 100 and a higher scale score indicates improved quality of life)."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "To investigate the efficacy of intravenous infusions of HB-adMSCs vs placebo in patients with Multiple Sclerosis as determined by improvements in the Multiple Sclerosis Quality of Life (MSQOL) 54 Instrument."
                        ],
                        "NCTId": [
                              "NCT05116540"
                        ]
                  },
                  {
                        "Rank": 14,
                        "OverallOfficialName": [
                              "Djamchid Lotfi, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Recruiting"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "July 20, 2023"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part II.",
                              "Treatment-emergent Adverse Event.",
                              "SSAEs.",
                              "Incidence of thromboembolic events.",
                              "Incidence and risk of AEs of special interest (serious or non-serious), including peripheral events defined as, thromboembolism of the extremities.",
                              "Incidence and risk of AEs of special interest (serious or non-serious), including infections.",
                              "Incidence and risk of AEs of special interest (serious or non-serious), including hypersensitivities.",
                              "Clinically significant changes in CBC values.",
                              "Number of Participants with changes in Laboratory CMP values",
                              "Number of Participants with changes in Laboratory Coagulation Panel values.",
                              "Number of Participants with Clinically significant changes in Respiratory Rate.",
                              "Number of Participants with Clinically significant changes in Heart Rate.",
                              "Number of participants with Clinically significant changes in Heart Rate.",
                              "Number of Participants with Clinically significant changes in Blood Pressure.",
                              "Number of Participants with Clinically significant changes in Weight in lb.",
                              "Number of Participants with Clinically significant changes in general physical examination results.",
                              "Number of Participants with Clinically significant changes in body systems physical examination results."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "1. Changes in the total score MDS-UPDRS Part II.",
                              "2. Incidence of treatment-emergent Adverse Event (TEAEs).",
                              "3. Incidence of treatment-emergent Serious Adverse Events (SAEs).",
                              "4. AEs of special interest (serious or non-serious) - thromboembolic events.",
                              "5. AEs of special interest (serious or non-serious) - thromboembolism of the extremities",
                              "6. AEs of special interest (serious or non-serious) - infections",
                              "7. AEs of special interest (serious or non-serious) - hypersensitivities.",
                              "8. Laboratory value Complete Blood Count (CBC)",
                              "9. Laboratory values Chemistry Metabolic Panel (CMP)",
                              "10. Laboratory values Coagulation Panel; Prothrombin time, Partial Prothrombin time, and INtern",
                              "11. Vital signs. - Respiratory Rate (breaths per minute)",
                              "12. Vital signs. - Heart Rate (beats per minute)",
                              "13. Vital signs. - Body Temperature (Fahrenheit )",
                              "14. Vital signs. - Blood Pressure (mmHg)",
                              "15. Weight in lb.",
                              "16. Physical examination results. General",
                              "17. Physical examination results. Body Systems."
                        ],
                        "NCTId": [
                              "NCT04995081"
                        ]
                  },
                  {
                        "Rank": 15,
                        "OverallOfficialName": [
                              "Djamchid Lotfi, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Active, not recruiting"
                        ],
                        "OversightHasDMC": [
                              "Yes"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "May 28, 2023"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "MDS-UPDRS Part II.",
                              "treatment-emergent Adverse Event.",
                              "SSAEs.",
                              "Incidence of thromboembolic events.",
                              "Incidence and risk of AEs of special interest (serious or non-serious), including peripheral events defined as, thromboembolism of the extremities.",
                              "Incidence and risk of AEs of special interest (serious or non-serious), including infections.",
                              "Incidence and risk of AEs of special interest (serious or non-serious), including hypersensitivities.",
                              "Clinically significant changes in CBC values.",
                              "Clinically significant changes in CMP values.",
                              "Clinically significant changes in Coagulation Panel values.",
                              "Clinically significant changes in Respiratory Rate.",
                              "Clinically significant changes in Heart Rate.",
                              "Clinically significant changes in Heart Rate.",
                              "Clinically significant changes in Blood Pressure.",
                              "Clinically significant changes in Weight in lb.",
                              "Clinically significant changes in general physical examination results.",
                              "Clinically significant changes in body systems physical examination results."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Changes in MDS-UPDRS Part II.",
                              "Incidence of treatment-emergent Adverse Event (TEAEs).",
                              "Incidence of treatment-emergent Serious Adverse Events (SAEs).",
                              "AEs of special interest (serious or non-serious) - thromboembolic events.",
                              "AEs of special interest (serious or non-serious) - thromboembolism of the extremities",
                              "AEs of special interest (serious or non-serious) - infections",
                              "AEs of special interest (serious or non-serious) - hypersensitivities.",
                              "Laboratory values. CBC",
                              "Laboratory values. CMP",
                              "Laboratory values. Coagulation Panel",
                              "Vital signs. - Respiratory Rate (breaths per minute)",
                              "Vital signs. - Heart Rate (beats per minute)",
                              "Vital signs. - Body Temperature (Fahrenheit )",
                              "Vital signs. - Blood Pressure (mmHg)",
                              "Weight in lb.",
                              "Physical examination results. General",
                              "Physical examination results. Body Systems."
                        ],
                        "NCTId": [
                              "NCT04928287"
                        ]
                  },
                  {
                        "Rank": 16,
                        "OverallOfficialName": [
                              "Walter R Lowe, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04604288"
                        ]
                  },
                  {
                        "Rank": 17,
                        "OverallOfficialName": [
                              "Rajiv Thakur, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04514952"
                        ]
                  },
                  {
                        "Rank": 18,
                        "OverallOfficialName": [],
                        "OverallOfficialRole": [],
                        "OverallStatus": [
                              "Recruiting"
                        ],
                        "OversightHasDMC": [
                              "No"
                        ],
                        "PatientRegistry": [],
                        "Phase": [
                              "Phase 2"
                        ],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [
                              "December 20, 2023"
                        ],
                        "PrimaryCompletionDateType": [
                              "Anticipated"
                        ],
                        "PrimaryOutcomeDescription": [
                              "Clinically significant changes in Visual Analog Scale - Extreme fatigue",
                              "Clinically significant changes in Visual Analog Scale - Brain fog",
                              "Clinically significant changes in Visual Analog Scale - Headache",
                              "Clinically significant changes in Visual Analog Scale - Sleep disturbances",
                              "Clinically significant changes in Visual Analog Scale - Loss of taste",
                              "Clinically significant changes in Visual Analog Scale - Loss of smell",
                              "Treatment-emergent Adverse Event.",
                              "SSAEs",
                              "Incidence of thromboembolic events.",
                              "Incidence and risk of AEs of special interest (serious or non-serious), including peripheral events defined as, thromboembolism of the extremities.",
                              "Incidence and risk of AEs of special interest (serious or non-serious), including infections.",
                              "Incidence and risk of AEs of special interest (serious or non-serious), including hypersensitivities.",
                              "Clinically significant changes in CBC values.",
                              "Clinically significant changes in CMP values.",
                              "Clinically significant changes in Coagulation Panel values.",
                              "Clinically significant changes in Respiratory Rate.",
                              "Clinically significant changes in Heart Rate.",
                              "Clinically significant changes in Body Temperature.",
                              "Clinically significant changes in Blood Pressure.",
                              "Clinically significant changes in Weight.",
                              "Clinically significant changes in general physical examination results.",
                              "Clinically significant changes in Body Systems physical examination results."
                        ],
                        "PrimaryOutcomeMeasure": [
                              "Changes in Visual Analog Scale of Neurological Symptoms. - Extreme fatigue",
                              "Changes in Visual Analog Scale of Neurological Symptoms. - Brain fog",
                              "Changes in Visual Analog Scale of Neurological Symptoms. - Headache",
                              "Changes in Visual Analog Scale of Neurological Symptoms. - Sleep disturbances",
                              "Changes in Visual Analog Scale of Neurological Symptoms. - Loss of taste",
                              "Changes in Visual Analog Scale of Neurological Symptoms. - Loss of smell",
                              "Incidence of treatment-emergent Adverse Event (TEAEs).",
                              "Incidence of treatment-emergent Serious Adverse Events (SAEs).",
                              "AEs of special interest (serious or non-serious) - thromboembolic events.",
                              "AEs of special interest (serious or non-serious) - thromboembolism of the extremities.",
                              "AEs of special interest (serious or non-serious) - infections.",
                              "AEs of special interest (serious or non-serious) - hypersensitivities.",
                              "Changes in Laboratory values. - CBC.",
                              "Changes in Laboratory values. - CMP.",
                              "Changes in Laboratory values. - Coagulation Panel.",
                              "Changes in Vital Signs. - Respiratory Rate (breaths per minute)",
                              "Changes in Vital Signs. - Heart Rate (beats per minute)",
                              "Changes in Vital Signs. - Body Temperature (Fahrenheit )",
                              "Changes in Vital Signs. - Blood Pressure (mmHg)",
                              "Changes in Weight in lb.",
                              "Changes in Physical examination results. - General",
                              "Changes in Physical examination results. - Body Systems"
                        ],
                        "NCTId": [
                              "NCT05126563"
                        ]
                  },
                  {
                        "Rank": 19,
                        "OverallOfficialName": [
                              "Djamchid Lotfi, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04772378"
                        ]
                  },
                  {
                        "Rank": 20,
                        "OverallOfficialName": [
                              "Thanh Cheng, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04798066"
                        ]
                  },
                  {
                        "Rank": 21,
                        "OverallOfficialName": [
                              "Djamchid Lotfi, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04711811"
                        ]
                  },
                  {
                        "Rank": 22,
                        "OverallOfficialName": [
                              "Djamchid Lotfi, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04825626"
                        ]
                  },
                  {
                        "Rank": 23,
                        "OverallOfficialName": [
                              "Djamchid Lotfi, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "Temporarily not available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04825613"
                        ]
                  },
                  {
                        "Rank": 24,
                        "OverallOfficialName": [
                              "Thanh Cheng, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT04064983"
                        ]
                  },
                  {
                        "Rank": 25,
                        "OverallOfficialName": [
                              "Djamchid Lotfi, MD"
                        ],
                        "OverallOfficialRole": [
                              "Principal Investigator"
                        ],
                        "OverallStatus": [
                              "No longer available"
                        ],
                        "OversightHasDMC": [],
                        "PatientRegistry": [],
                        "Phase": [],
                        "PointOfContactEMail": [],
                        "PointOfContactOrganization": [],
                        "PointOfContactPhone": [],
                        "PointOfContactPhoneExt": [],
                        "PointOfContactTitle": [],
                        "PrimaryCompletionDate": [],
                        "PrimaryCompletionDateType": [],
                        "PrimaryOutcomeDescription": [],
                        "PrimaryOutcomeMeasure": [],
                        "NCTId": [
                              "NCT05154851"
                        ]
                  }
            ]
      }
}